Shervin R. Dashti, Ph.D.
Affiliations: | 2001 | Case Western Reserve University School of Medicine, Cleveland, OH, United States |
Area:
Cell Biology, Molecular BiologyGoogle:
"Shervin Dashti"Mean distance: (not calculated yet)
Parents
Sign in to add mentorRichard L. Eckert | grad student | 2001 | Case Western Medical School | |
(MEK6 and MEK7 regulate human involucrin gene expression via a p38 MAP kinase-dependent mechanism.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Eckert RL, Crish JF, Efimova T, et al. (2004) Regulation of involucrin gene expression. The Journal of Investigative Dermatology. 123: 13-22 |
Sturniolo MT, Dashti SR, Deucher A, et al. (2003) A novel tumor suppressor protein promotes keratinocyte terminal differentiation via activation of type I transglutaminase. The Journal of Biological Chemistry. 278: 48066-73 |
Eckert RL, Efimova T, Balasubramanian S, et al. (2003) p38 Mitogen-activated protein kinases on the body surface--a function for p38 delta. The Journal of Investigative Dermatology. 120: 823-8 |
Eckert RL, Efimova T, Dashti SR, et al. (2002) Keratinocyte survival, differentiation, and death: many roads lead to mitogen-activated protein kinase. The Journal of Investigative Dermatology. Symposium Proceedings / the Society For Investigative Dermatology, Inc. [and] European Society For Dermatological Research. 7: 36-40 |
Dashti SR, Efimova T, Eckert RL. (2001) MEK6 regulates human involucrin gene expression via a p38alpha - and p38delta -dependent mechanism. The Journal of Biological Chemistry. 276: 27214-20 |
Dashti SR, Efimova T, Eckert RL. (2001) MEK7-dependent activation of p38 MAP kinase in keratinocytes. The Journal of Biological Chemistry. 276: 8059-63 |
Deucher A, Nagpal S, Chandraratna RA, et al. (2000) The carboxy-terminal hydrophobic domain of TIG3, a class II tumor suppressor protein, is required for appropriate cellular localization and optimal biological activity. International Journal of Oncology. 17: 1195-203 |